Increased secretion and activity of matrix metalloproteinase-3 in synovial tissues and chondrocytes from experimental osteoarthritis

Osteoarthritis and Cartilage

Volumn 6, Issue 4, 1998, Pages 286-294

  Mehraban, By Fuad ^a   Lark, Michael W ^b,c   Ahmed, Farah N ^a   Xu, Fong ^a   Moskowitz, Roland W ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cartilage; Metalloproteinase; Osteoarthritis; Synovium

Indexed keywords

STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME RELEASE; EXPERIMENTAL MODEL; FEMALE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; RABBIT; SYNOVIUM;

EID: 0032126319     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.1998.0122     Document Type: Article

References (38)

1. 1. Murphy G, Hembry RM, Hughes CE, Fosang A, Hardingham TE. Role and regulation of metalloproteinases in connective tissue turnover. Biochem Soc Trans. 1990;18:812-5.
2. 2. Woessner JF Jr, Gunja-Smith Z. Role of metalloproteinases in human osteoarthritis. J Rheumatol. 1991;27Suppl:99-101.
3. 3. Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier J-P. Excess of metalloproteinase over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest. 1994;70:807-15.
4. 4. Mehraban F, Kuo S-Y, Riera H, Chang C, Moskowitz RW. Prostromelysin and procollagenase genes are differentially up-regulated in chondrocytes from the knees of rabbits with experimental osteoarthritis. Arthritis Rheum. 1994;37:1189-97.
5. 5. Fosang AJ, Last K, Maciewics RA. Aggrecan is degraded by matrix metalloproteinases in human arthritis: Evidence that matrix metalloproteinase and aggrecanase activities can be independent. J Clin Invest. 1996;98:2292-99.
6. 6. Baici A, Lang A, Horler D, Kissling R, Merlin C. Cathepsin B in osteo arthritis: cytochemical and histochemical analysis of human femoral head cartilage. Annals Rheum Dis. 1995;54:289-97.
7. 7. Baici A, Horler D, Lang A, Merlin C, Kissling R. Cathepsin B in osteoarthritis: zonal variation of enzyme activity in human femoral head. Annals Rheum Dis. 1995;54:281-8.
8. 8. Mehraban F, Tindal MH, Proffitt MM, Moskowitz RW. Temporal pattern of cystein endopeptidase (cathepsin B) expression in cartilage and synovium from rabbit knees with experimental osteoarthritis: gene expression in chondrocytes in response to interleukin-1 and matrix depletion. Annals Rheum Dis. 1997;56:108-15.
9. 9. Martel-Pelletier J, Faure MP, McCollum R, Mineau F, Cloutier JM, Pelletier J-P. Plasmin, plasminogen activators and inhibitor in human osteoarthritis cartilage. J Rheumatol. 1991;18:1863-71.
10. 10. Kikuchi H, Shimada W, Nonaka T, Ueshima S, Tanaka S. Significance of serine proteinase and matrix metalloproteinase systems in the destruction of human articular cartilage. Clinical Exp Pharm Phys. 1996;23:885-9.
11. 11. Vignon E, Balbalnc J, Mathieu P, Louisot P, Richard M. Metalloprotease activity, phospholipase A2 activity and cytokine concentration in osteoarhtritis synovial fluid. Osteoarthr Car. 1993;1:115-20.
12. 12. Zanfarullah M, Pelletier JP, Cloutier JM, Martel-Pelletier J. Elevated metalloproteinase and tissue inhibitor of metalloproteinase mRNA in human osteoarthritic synovia. J Rheumatol. 1993;20:693-7.
13. 13. Lohmander LS, Hoerrner LA, Lark MW. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum. 1993;36:181-9.
14. 14. Reboul P, Pelletier JP, Tardif G, Cloutier JM, Martel-Pelletier J. The new collagenase, collagense-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. J Clin Invest. 1996;97:2011-9.
15. 15. Hasty KA, Jeffrey JJ, Hibbs MS, Welgus HG. The collagen substrate specificity of human neutrophil collagenase. J Biol Chem. 1987;262:10048-52.
16. 16. Hasty KA, Pourmotabbed TF, Goldberg GI, Thompson JP, Spinella DG, Stevens RM, Mainardi CL. Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. J Biol Chem. 1990;265:11421-4.
17. 17. Pelletier J-P, Martel-Pelletier J, Altman RD, Ghandur-Mnaymneh L, Howell DS, Woessner Jr JF. Collagenolytic activity and collagen matrix breakdown of the articular cartilage in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum. 1983;26:866-74.
18. 18. Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole RA. Damage to type II collagen in aging and osteoarthritis starts in the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest. 1995;96:2859-69.
19. 19. Flannery C, Lark MW, Sandy JD. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. J Biol Chem. 1992;267:1008-14.
20. 20. Fosang AJ, Neame PJ, Last K, Hardingham TE, Murphy G. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinase and cathepsin B. J Biol Chem. 1992;267:19470-4.
21. 21. Fosang AJ, Last K, Knauper V, Neame PJ, Murphy G, Hardingham TE, Tschesche H, Hamilton JA. Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain. Biochem J. 1993;295:273-6.
22. 22. Nguyen Q, Liu J, Roughley PJ, Mort JS. Link protein as a monitor in situ of endogenous proteolysis in adult human articular cartilage. Biochem J. 1991;278:143-7.
23. 23. Freije JM, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, Lopez-Otin C. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem. 1994;269:16766-73.
24. 24. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, Geoghegan KF, Hambor JE. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest. 1996;97:761-8.
25. 25. Fosang AJ, Last K, Knauper V, Murphy G, Neame PJ. Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett. 1996;380:17-20.
26. 26. Mehraban F, Ahmed FN, Moskowitz RW. In vitro activities of matrix metallproteinases 1, 3, and 13 against synthetic collagen and aggrecan target sequences (abstract). Trans Orthop Res Soc. 1997;22:461.
27. 27. Dean DD, Martel-Pelletier J, Pelletier J-P, Howell DS, Woessner JJF. Evidence for metalloproteinase and metalloproteinase inhibitor (TIMP) imbalance in human osteoarthritic cartilage. J Clin Invest. 1989;84:678-85.
28. 28. Sandy JD, Flannery CR, Neame PJ, Lohmander LS. The structure of aggrecan fragments in human synovial fluid. J Clin Invest. 1992;89:1512-6.
29. 374 in the interglobular domain of cartilage aggrecan. Biochem J. 1994;384:347-51.
30. 30. Moskowitz RW, Davis W, Sammarco J, Martens M, Baker J, Mayer M, Burstein AH, Frankel VH. Experimentally induced degenerative joint lesions following partial meniscectomy in the rabbit. Arthritis Rheum. 1973;16:397-405.
31. 31. Harrison R, Teahan J, Stein R. A semicontinuous, high-performance liquid chromatography based assay for stromelysin. Anal Biochem. 1989;180: 110-3.
32. 32. Ganu VS, Hu S-I, Melton R, Winter C, Goldberg VM, Haqqi TM, Malemud CJ. Biochemical and molecular characterization of stromelysin synthesized by human osteoarthritic chondrocytes stimulated with recombinant human interleukin-1. Clin Exp Rheum. 1994;12:489-96.
33. 33. Cooksley S, Hipkiss JB, Tickle SP, Holmes-Ievers E, Docherty AJP, Murphy G, Lawson ADG. Immunoassays for the detection of human collagenase, stromelysin, tissue inhibitor of metalloproteinases (TIMP) and enzyme inhibitor complexes. Matrix. 1990;10:285-91.
34. 34. Lohmander LS, Roos H, Dahlberg L, Hoerrner LA, Lark MW. Temporal patterns of stromelysin-1, tissue inhibitor, and proteoglycan fragments in human knee joint fluid after injury to the cruciate ligament or meniscus. J Orthop Res. 1994;12:21-8.
35. 35. Docherty AJ, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJ , Murphy G, Reynolds JJ. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature. 1985;318:66-9.
36. 36. Whitham SE, Murphy G, Angel P, Rahmsdorf HJ, Smith BJ, Lyons A, Harris TJ, Reynolds JJ, Herrlich P, Docherty AJ. Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem J. 1986;240:913-6.
37. 37. Buttner FH, Chubinskaya S, Mergerie D, Huch K, Flechtenmacher J, Cole AA, Kuettner K, Bartnik E. Expression of membrane type1 matrix me talloproteinase in human articular cartilage. Arthritis Rheum. 1997;40:704-9.
38. 38. Pelletier J-P, Mineau F, Faure M-P, Martel-Pelletier J.Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis. Arthritis Rheum. 1990;33:1466-76.